About Andson Biotech
Andson Biotech is a private company based in Atlanta, Georgia, incorporated in 2021 in Delaware. It has reported $8,335,000 raised in two offerings on Form D since March 2024. Its chief executive is Mason Chilmonczyk.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 17, 2025 | Oct 22, 2025 | $4,735,000of $5.0M target | 29 | $163K | EquityRule 506(b) | Form D ↗ |
| Mar 12, 2024 | Mar 26, 2024 | $3,600,000fully sold | 37 | $97,297 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $8,335,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Andson Biotech's Form D filed Oct 22, 2025.
AF
Andrei Fedorov
Director
MC
Mason Chilmonczyk
Chief Executive Officer and director
JF
Jim Filippini
Executive officer
TB
Thomas O'Brien
Director
GE
Glenn Epstein
Director
JR
James Ross
Director